JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoder, K. K.
Right arrow Articles by Morris, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoder, K. K.
Right arrow Articles by Morris, E. D.
Journal of Nuclear Medicine Vol. 45 No. 5 903-911
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Change in Binding Potential as a Quantitative Index of Neurotransmitter Release Is Highly Sensitive to Relative Timing and Kinetics of the Tracer and the Endogenous Ligand

Karmen K. Yoder, PhD1, Chunzhi Wang, MS1 and Evan D. Morris, PhD1,2

1 Division of Research, Section of Imaging Science, Department of Radiology, Indiana University School of Medicine, Indianapolis, Indiana
2 Department of Biomedical Engineering, Purdue School of Engineering and Technology, Indiana University—Purdue University, Indianapolis, Indiana

Change in binding potential ({Delta}BP) is often used to indicate alterations in neurotransmitter concentration in response to stimuli. Increasingly, it is being used in bolus studies as a quantitative index of dopamine (DA) release. In bolus studies, however, BP is an average quantity over time that is influenced by the dynamics of both the tracer and the neurotransmitter. We sought to characterize the sensitivity of {Delta}BP to changes in endogenous DA concentration and to elucidate possible biases in {Delta}BP with respect to timing of task-induced or drug-induced increases in DA. Methods: Noiseless simulations of 11C-raclopride PET curves were performed in a specific binding region with concomitant increases in endogenous DA. DA changes were modeled as {delta}-functions, {gamma}-variates, or as realistic drug-induced increases in DA over time, based on published results. Graphical estimation of BP with a reference region as the input function was used, with a multilinear formulation of the operational equation. Results: Simulations demonstrated that {Delta}BP (a) is linear over a narrow range of integrated DA release, (b) has an inherent sensitivity to timing of DA perturbations, and (c) could incorrectly infer the relative amounts of DA released between subject populations or experimental conditions. These results are explained by what we term the effective weighted availability, which describes the interaction of a DA function and free raclopride concentration over time and follows directly from earlier work. Conclusion: We illustrate how, under quite plausible circumstances, {Delta}BP may lead to erroneous conclusions about relative amounts of DA released after dopaminergic perturbations. Our findings caution against using {Delta}BP as a quantitative or rank index of DA release when comparing different dopaminergic stimuli.

Key Words: binding potential • kinetics • sensitivity • bias • neurotransmitter release







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.